Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹139.10
Market cap: ₹52.04 Cr
Revenue (annual): ₹12.11 Cr
Net profit (annual): ₹-4.16 Cr
P/E (TTM): -43.5×Sector 47.4×
Promoter holding: 64.66%+33.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 5 Other Announcement 2 Open Offer 2 Promoter Selling (Off-Market) 1 Promoter Reclassification 1 Promoter Buying 1 Management Change 1 Financial Results 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Aug 2026 22:10 IST BSE

Management Change

Parmax Pharma Management Change

Parmax Pharma Limited announced the appointment of Dhiren Shah and Sunil Shah as Directors. Additionally, Ms. Salma Thobhani resigned as a Non-Executive Non-Independent Director.

Read the filing ↗